Molloy W D, Lee K Y, Girling L, Schick U, Prewitt R M
Am Rev Respir Dis. 1984 Nov;130(5):870-4. doi: 10.1164/arrd.1984.130.5.870.
Despite the high mortality (greater than 30%) associated with hypotension complicating pulmonary embolism, previous studies have not systematically investigated how best to treat shock resulting from pulmonary embolism. In 24 dogs, we measured relevant hemodynamic parameters before and after shock was produced by intravenously injected autologous blood clots. When systemic blood pressure fell to 70 mmHg, dogs were randomly divided into groups and treated blindly for 1 h. All control dogs and all dogs treated with volume and isoproterenol died. In contrast, all dogs treated with noradrenaline were resuscitated and remained hemodynamically stable for 1 h. This effect of noradrenaline was significant (p less than 0.01, Fisher's exact test). Noradrenaline improved right ventricular performance by increasing blood pressure and improving right ventricular perfusion and/or by a direct increase in contractility. We conclude that in a canine model of pulmonary embolism and shock, noradrenaline may be the drug of choice for acute resuscitation.
尽管与肺栓塞并发的低血压相关的死亡率很高(超过30%),但以往的研究尚未系统地探讨如何最佳地治疗肺栓塞所致的休克。我们对24只狗静脉注射自体血凝块制造休克,在休克前后测量相关血流动力学参数。当体循环血压降至70 mmHg时,将狗随机分组并进行盲法治疗1小时。所有对照狗以及所有接受容量治疗和异丙肾上腺素治疗的狗均死亡。相比之下,所有接受去甲肾上腺素治疗的狗均复苏成功,并且血流动力学在1小时内保持稳定。去甲肾上腺素的这种作用具有显著性(p<0.01,Fisher精确检验)。去甲肾上腺素通过升高血压、改善右心室灌注和/或直接增加心肌收缩力来改善右心室功能。我们得出结论,在犬类肺栓塞和休克模型中,去甲肾上腺素可能是急性复苏的首选药物。